Feeling sick?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Liraglutide (Victoza)

Also known as Victoza

Liraglutide (NN2211), marketed under the brand name Victoza, is a long-acting glucagon-like peptide-1 agonist (GLP-1 agonist) developed by Novo Nordisk for the treatment of type 2 diabetes. The product was approved by the European Medicines Agency (EMA) on July 3, 2009, and by the U.S. Food and Drug Administration (FDA) on January 25, 2010.

Source: Wikipedia

Estimated Total Cost: $296.67 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed liraglutide to treat diabetes, rabies, blastomycosis, and west nile virus.

Ajax-loader Loading...